How effective are blue-light filtering IOLs in preventing nAMD?
Use of a blue-light filtering (BLF) intraocular lens (IOL) does not offer any clear advantage over a non-BLF IOL in the incidence of neovascular age-related macular degeneration (nAMD) or its progression, nor in clinical variables associated with nAMD severity, among patients who underwent cataract surgery, results of a study have shown.